ADVFN US – Market Content Editor

  • Cava Shares Plunge Premarket After Company Cuts Full-Year Sales Guidance

    Cava Shares Plunge Premarket After Company Cuts Full-Year Sales Guidance

    Cava (NYSE:CAVA) saw its shares drop 22% in premarket trading in the U.S. following a reduction in its annual restaurant sales forecast. The Mediterranean-focused chain reported quarterly earnings of $0.16 per share for the period ending in June, above analysts’ consensus of $0.13 per share. Revenue climbed 20% year-over-year to $280.6 million, slightly below expectations…

  • Nasdaq, S&P 500 Rally To New Record Highs Following Inflation Data

    Nasdaq, S&P 500 Rally To New Record Highs Following Inflation Data

    After ending Monday’s choppy trading session moderately lower, stocks showed a strong move back to the upside during trading on Tuesday. The major averages more than offset the losses posted in the previous session, with the Nasdaq and the S&P 500 reaching new record closing highs. The major averages ended the session near their best…

  • Musk and Altman Clash Again as AI Leaders Accuse Each Other of Platform Manipulation

    Musk and Altman Clash Again as AI Leaders Accuse Each Other of Platform Manipulation

    The ongoing public feud between tech CEOs Elon Musk and Sam Altman flared up once more Tuesday, as both exchanged sharp accusations over alleged algorithmic manipulation on their platforms. The conflict reignited Monday when Musk accused Apple (NASDAQ:AAPL) of favoring OpenAI’s ChatGPT over his own AI chatbot Grok on the App Store, branding it an…

  • Amphastar Shares Climb on Exclusive Licensing Deal for Three Peptide Therapies

    Amphastar Shares Climb on Exclusive Licensing Deal for Three Peptide Therapies

    Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock rise 5.6% after securing an exclusive licensing agreement with Nanjing Anji Biotechnology for three proprietary peptide-based therapies aimed at oncology and ophthalmology markets. Under the deal, Amphastar gains exclusive rights to develop, produce, and market the therapies in the United States and Canada. The first candidate is an endogenous…

  • 180 Life Sciences Stock Surges 75% Following Disclosure of Large Ethereum Holdings

    180 Life Sciences Stock Surges 75% Following Disclosure of Large Ethereum Holdings

    180 Life Sciences Corp. (NASDAQ:ATNF), now operating under the name ETHZilla, experienced a sharp 75% increase in its stock price after announcing it holds 82,186 Ethereum tokens valued at roughly $349 million. The company revealed it acquired this sizable ETH position at an average cost of $3,806.71 per token. Alongside its cryptocurrency assets, ETHZilla also…

  • Trinity Biotech Shares Jump 4.4% After Successful Calibration-Free CGM Trial

    Trinity Biotech Shares Jump 4.4% After Successful Calibration-Free CGM Trial

    Trinity Biotech plc (NASDAQ:TRIB) saw its stock increase by 4.4% following the announcement of promising clinical trial outcomes for its next-generation continuous glucose monitoring (CGM) system. The biotech firm revealed that its newly engineered needle-free glucose sensor provided precise glucose measurements over a full 15-day wear period without the need for finger-stick calibration. This breakthrough…

  • ProPhase Labs Shares Surge 38% Following Patent Approval for Esophageal Disease Test

    ProPhase Labs Shares Surge 38% Following Patent Approval for Esophageal Disease Test

    ProPhase Labs Inc (NASDAQ:PRPH) saw its stock jump 38% after securing a crucial patent for its biomarker-based system that evaluates progression risk in Barrett’s esophagus and esophageal adenocarcinoma. The United States Patent and Trademark Office granted U.S. Patent No. 12379378-B2 for the proprietary methods supporting ProPhase’s BE-Smart™ molecular diagnostic test. This milestone follows the company’s…

  • Sinclair Shares Jump 20% Amid Strategic Review of Broadcast Unit

    Sinclair Shares Jump 20% Amid Strategic Review of Broadcast Unit

    Shares of Sinclair, Inc. (NASDAQ:SBGI) surged 20% following the announcement of a broad strategic review targeting its broadcast business, indicating possible moves toward consolidation within the industry. The company’s board has unanimously approved an assessment to explore opportunities that could enhance shareholder value, including potential acquisitions, partnerships, or mergers with other players in the broadcast,…

  • USA Rare Earth Jumps 20% on Magnet Supply Deal with Enduro Pipeline Services

    USA Rare Earth Jumps 20% on Magnet Supply Deal with Enduro Pipeline Services

    USA Rare Earth, Inc. (NASDAQ:USAR) shares climbed 20% after the company revealed it had signed a memorandum of understanding (MOU) with Enduro Pipeline Services to provide U.S.-manufactured neodymium magnets for pipeline cleaning equipment. Per the agreement, USA Rare Earth will supply magnets for Enduro’s “intelligent pigs” — specialized tools that clean and inspect pipelines using…

  • AAR Corp Buys Aerostrat in $15 Million Deal to Boost Aviation Software Portfolio

    AAR Corp Buys Aerostrat in $15 Million Deal to Boost Aviation Software Portfolio

    AAR CORP. (NYSE:AIR), a leader in aviation services, has purchased Aerostrat, a specialist in long-range maintenance planning software, for $15 million, with the potential for an additional $5 million in contingent payments. The move strengthens AAR’s digital solutions portfolio and enhances the enterprise resource planning (ERP) capabilities of its Trax subsidiary. Aerostrat’s signature product, Aerros,…